Senin, 15 Maret 2021

COVID-19: Germany, France and Italy suspending Oxford-AstraZeneca coronavirus vaccine amid blood clot concerns - Sky News

Germany, France and Italy are suspending use of the Oxford-AstraZeneca coronavirus vaccine as EU regulators investigate reports some people developed blood clots after having the jab.

The German health ministry, the Italian medicines authority and French president Emmanuel Macron said the measure was a "precaution" as the European Medicines Agency (EMA) looks into the matter.

Mr Macron added EU regulators were expected to give guidance on Tuesday afternoon.

The countries are the latest European nations to halt administering the AstraZeneca vaccine amid concerns over possible links to the clots.

Live COVID updates from the UK and around the world

Professor Andrew Pollard, director of the Oxford vaccine group which developed the jab, has said there is "very reassuring evidence that there is no increase in a blood clot phenomenon here in the UK, where most of the doses in Europe have been given so far".

AstraZeneca has said there is no cause for concern.

More from Covid-19

The company said it had conducted a review covering more than 17 million people vaccinated in the EU and the UK which had shown no evidence of an increased risk of blood clots.

Both the EMA and the UN agency World Health Organisation have said available data does not suggest the vaccine caused the clots and that people should continue to be immunised.

In a statement, the German health ministry said its decision to suspend the jab was taken on the advice of national vaccine regulator, the Paul Ehrlich Institute (PEI).

The PEI has called for further investigation into seven reported cases of clots in the brains of people who had been vaccinated.

The EMA said on Friday several cases of immune thrombocytopenia - a lack of platelets in the blood that can lead to bleeding and bruising - had been reported under its vaccine safety monitoring process.

Blood clots can travel through the body and cause heart attacks, strokes and deadly blockages in the lungs.

German health minister Jens Spahn said his country's decision to stop using the vaccine was not political and while the risk of blood clots is low it cannot be ruled out.

Mr Macron said he hopes "we can resume quickly" administering the vaccine "if the EMA gives the green light".

He added: "We are therefore suspending its use until tomorrow afternoon."

Please use Chrome browser for a more accessible video player

Oxford jab: What are the concerns?

In the US, results of an AstraZeneca trial there are being reviewed to determine if the shot is safe and effective.

If the data is positive and all goes well, the US Food and Drug Administration could issue an emergency use authorisation in about a month, said director of the National Institutes of Health, Dr Francis Collins.

He said he had been "pretty reassured" by statements from European regulators that the blood clot problems could be happening by chance, and are not related to the vaccine.

On Sunday, Ireland temporarily suspended the shot "out of an abundance of caution" after reports from Norway of serious blood clotting in some recipients there.

Three health workers in Norway who recently received the AstraZeneca vaccine were being treated in hospital for bleeding, blood clots and a low count of blood platelets, its health authorities said on Saturday.

TOPSHOT - French President Emmanuel Macron chairs a video conference with foreign compagnies executives on November 6, 2020 at the Elysee presidential Palace in Paris, as part of a "mini choose France" forum, designed to attract more foreign businesses. (Photo by Ludovic MARIN / POOL / AFP) (Photo by LUDOVIC MARIN/POOL/AFP via Getty Images)
Image: Mr Macron said the EU medicine regulator was expected to give guidance on the vaccine on Tuesday afternoon

Irish authorities received some reports of clotting similar to those seen in mainland Europe last week but nothing as serious as the Norwegian cases, according to Deputy Chief Medical Officer Ronan Glynn.

Denmark, Norway and Iceland have suspended the use of the vaccine over reported clotting issues.

And on Friday, Thailand became the first nation outside of Europe to do so, delaying its AstraZeneca rollout over the safety concerns in the EU. Other countries temporarily halting its use include the Netherlands, Congo and Bulgaria.

Authorities in Italy's northern region of Piedmont said they would stop using a batch of AstraZeneca vaccines after a 57-year-old teacher died on Sunday following his vaccination a day earlier.

Post-mortem examinations have been ordered for his death, as well as several other fatalities last week in Italy of people who had received the vaccine.

Austria also halted using a particular batch last week.

Let's block ads! (Why?)


https://news.google.com/__i/rss/rd/articles/CBMifWh0dHBzOi8vbmV3cy5za3kuY29tL3N0b3J5L2NvdmlkLTE5LWdlcm1hbnktc3VzcGVuZHMtb3hmb3JkLWFzdHJhemVuZWNhLWNvcm9uYXZpcnVzLXZhY2NpbmUtYW1pZC1ibG9vZC1jbG90LWNvbmNlcm5zLTEyMjQ2OTM20gGBAWh0dHBzOi8vbmV3cy5za3kuY29tL3N0b3J5L2FtcC9jb3ZpZC0xOS1nZXJtYW55LXN1c3BlbmRzLW94Zm9yZC1hc3RyYXplbmVjYS1jb3JvbmF2aXJ1cy12YWNjaW5lLWFtaWQtYmxvb2QtY2xvdC1jb25jZXJucy0xMjI0NjkzNg?oc=5

2021-03-15 16:07:30Z
52781434532640

Tidak ada komentar:

Posting Komentar